May. 15 at 7:16 PM
$NCNA $NCNA I don't kwow who Viktoras is but He/She is alright with me.
Viktoras Karapetjanc, expert at Traders Union, sees NuCana's latest business update and ongoing clinical development as constructive signals for medium-term sentiment. He believes pipeline progress, combined with a positive reaction to the Q1 2026 results, underpins stronger investor confidence. While technicals point to likely consolidation, the momentum in R&D is a supportive factor for the bulls. "If buyers can defend the
$2.08 support region, I expect the fundamental story to help NCNA attempt a push back toward
$2.31 and possibly
$2.60 in the near term."
